2019 ASTRO PRESENTATIONS
Monday, September 16, 2019
-
MO-45-3463 Poster: Risk of Acute and Late Xerostomia in Pediatric Head and Neck Cancer Patients Treated with Radiotherapy: Initial Results from the PENTEC Initiative, Ramiro Pino, Houston Methodist Hospital
-
MO-44-3461 Poster: Spermatogenesis after Testicular Radiation Exposure in Children: Initial Results from the PENTEC Initiative, Rebecca Howell, MD Anderson Cancer Center
-
#1126 MO 10 Physics 4 - Outcomes Analysis and Modeling: Radiation-Associated Kidney Injury in Pediatric Cancer Patients: Results from the PENTEC Initiative, Matthew Poppe, MD, University of Utah
Tuesday, September 17, 2019
-
MO 13-Pediatric 1: *#1162: Modeling the Risk of Hearing Loss from Radiotherapy in Childhood Cancer Survivors: Initial Results from the PENTEC Hearing Loss Task Force, Torunn Yock, MD, MCH, Massachusetts General Hospital
-
EDU 17 (Interactive) Radiation Therapy-Related Cardiac Risk in Childhood Cancer Survivors - Informing Clinical Decisions, Rebecca Howell, PhD, MD Anderson Cancer Center *Radiation-associated cardiac disease, contrasting PENTEC and QUANTEC: Kids vs. grown-ups!, Louis Constine, MD, FARC, University of Rochester
-
EDU19-PENTEC: *Pediatric Normal Tissue Effects in the Clinic: An International Collaboration to Synthesize Data on Normal Tissue Radiation Dose-Volume Tolerances as Impacted by Development for Pediatric Cancer Patients, Louis Constine, MD, FACR *Curing Children with Cancer, But at What Cost? PENTEC: Pediatric Normal Tissue Effects in the Clinic - Overview of Results from Multiple International Task Forces, Louis Constine, MD, FACR, University of Rochester
-
SS 29-Physics 7: Outcome Analysis and Modeling *Hypothyroidism After Radiotherapy in Children: Initial Results of Thyroid Gland Dose-Response Relationship from the PENTEC Initiative, Ivan Vogelius, Rigshospitalet *Methodologic Pitfalls in Determining Radiation Dose Constraints in Pediatric Organs and the Path Forward, Soren Bentzen, DSc, PhD, University of Maryland *Modeling Normal Tissue Complication Probabilities in Children with Examples from PENTEC Task Forces, Andrew Jackson, PhD, Memorial Sloan Kettering Cancer Center *Clinical Modifiers of Dose-Risk Relationships in Childhood Cancer Survivors-Results from PENTEC Organ System Task Forces, David Hodgson, MD, Princess Margaret Cancer Center, Canada
Wednesday, September 18, 2019
-
SS 38-Pediatric 2: *Cardiac Disease in Childhood Cancer Survivors Treated with Radiotherapy: Final Results from the PENTEC Group, James Bates, MD, University of Florida